• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Role of GSK3b-mediated suppression of cardiac hypertrophy in heart failure

Research Project

Project/Area Number 25670130
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeMulti-year Fund
Research Field General pharmacology
Research InstitutionKyushu University

Principal Investigator

Morimoto Sachio  九州大学, 医学(系)研究科(研究院), 准教授 (50202362)

Co-Investigator(Renkei-kenkyūsha) TAKAHASHI Fumi  九州大学, 大学院医学研究院, 講師 (50274436)
Research Collaborator Mohamed Rasha  
Project Period (FY) 2013-04-01 – 2016-03-31
Project Status Completed (Fiscal Year 2015)
Budget Amount *help
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2015: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywords拡張型心筋症 / GSK3β / 心臓リモデリング / 心臓収縮機能 / 生命予後 / 心不全 / ノックアウトマウス / ノックインマウス / 心肥大抑制 / セレコキシブ / ジメチルセレコキシブ
Outline of Final Research Achievements

GSK3β plays a central role in both cardiac physiology and pathology. Herein we generated a mouse model carrying a heterozygous knock-out mutation of GSK3β (GSK3β +/- KO) together with a ΔK210 knock-in mutation in cardiac troponin T (ΔK210 cTnT KI), which was proved to be one of the genetic causes of familial dilated cardiomyopathy (DCM). GSK3β +/- KO prevented the slow and rapid deterioration in left ventricular systolic function accompanying heart failure (HF) in DCM mice with heterozygous and homozygous ΔK210 cTnT KI mutations, respectively. GSK3β +/- KO also prevented cardiac enlargement, myocardial fibrosis and cardiomyocyte apoptosis and markedly reduced the expression of cardiac β-myosin heavy chain isoform, indicative of HF, in DCM mice with homozygous ΔK210 cTnT KI mutation. GSK3β +/- KO also extended the life-span of these DCM mice. This study suggests that the inhibition of GSK3β is cardioprotective in familial DCM associated with ΔK210 cTnT mutation.

Report

(4 results)
  • 2015 Annual Research Report   Final Research Report ( PDF )
  • 2014 Research-status Report
  • 2013 Research-status Report
  • Research Products

    (10 results)

All 2016 2015 2014 2013 Other

All Journal Article (4 results) (of which Peer Reviewed: 4 results,  Acknowledgement Compliant: 2 results,  Open Access: 1 results) Presentation (4 results) Remarks (2 results)

  • [Journal Article] GSK3β heterozygous knockout is cardioprotective in a knock-in mouse model of familial dilated cardiomyopathy2016

    • Author(s)
      Rasha Mohamed · Sachio Morimoto · Islam Ibrahim · Dong-Yun Zhan · Cheng-Kun Du · Masaki Arioka · Tatsuya Yoshihara · Fumi Takahashi-Yanaga · Toshiyuki Sasaguri
    • Journal Title

      Am J Physiol Heart Circ Physiol

      Volume: in press Issue: 11 Pages: H1808-H1815

    • DOI

      10.1152/ajpheart.00771.2015

    • Related Report
      2015 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Stage-dependent benefits and risks of pimobendan in genetic dilated cardiomyopathy mice with progressive heart failure.2015

    • Author(s)
      Nonaka M, Morimoto S, Murayama T, Kurebayashi N, Li L, Wang YY, Arioka M, Yoshihara T, Takahashi-Yanaga F, Sasaguri T.
    • Journal Title

      British Journal of Pharmacology

      Volume: 172 Issue: 9 Pages: 2369-2382

    • DOI

      10.1111/bph.13062

    • Related Report
      2014 Research-status Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Journal Article] Experimental models of inherited cardiomyopathy and its therapeutics2014

    • Author(s)
      Nonaka M, Morimoto S
    • Journal Title

      World Journal of Cardiology

      Volume: 6 Issue: 12 Pages: 1245-1251

    • DOI

      10.4330/wjc.v6.i12.1245

    • Related Report
      2014 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Inherited cardiomyopathies caused by troponin mutations2013

    • Author(s)
      Lu Q-W, Wu X-Y, Morimoto S.
    • Journal Title

      Journal of Geriatric Cardiology

      Volume: 10 Pages: 91-101

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Presentation] GSK3βヘテロノックアウトは家族性拡張型心筋症モデルマウスにおいて心臓保護的に働く(口演)2016

    • Author(s)
      Mohamed R、森本 幸生、Ibrahim I、有岡 将基、吉原 達也、高橋 富美、笹栗 俊之
    • Organizer
      第89回 日本薬理学会年会
    • Place of Presentation
      横浜
    • Year and Date
      2016-03-09
    • Related Report
      2015 Annual Research Report
  • [Presentation] GSK3β heterozygous knockout is cardioprotective in familial dilated cardiomyopathy mouse model(口演)2015

    • Author(s)
      Mohamed R, Morimoto S, Ibrahim I, Arioka M, Yoshihara T, Takahashi-Yanaga F, Sasaguri T.
    • Organizer
      第68回 日本薬理学会西南部会
    • Place of Presentation
      下関
    • Year and Date
      2015-11-22
    • Related Report
      2015 Annual Research Report
  • [Presentation] Effect of pimobendan on end-stage heart failure in a mouse model of inherited dilated cardiomyopathy2015

    • Author(s)
      野中 美希、森本 幸生
    • Organizer
      第88回 日本薬理学会年会
    • Place of Presentation
      名古屋
    • Year and Date
      2015-03-18 – 2015-03-20
    • Related Report
      2014 Research-status Report
  • [Presentation] 心肥大モデルマウス、GSK-3βノックアウトマウスを用いたセレコキシブ・ジメチルセレコキ シブの効果2014

    • Author(s)
      藤田 愛、高橋 富美、森本 幸生、笹栗 俊之
    • Organizer
      日本薬理学会年会
    • Place of Presentation
      仙台
    • Related Report
      2013 Research-status Report
  • [Remarks] 九州大学大学院医学研究院臨床薬理学分野

    • URL

      http://www.med.kyushu-u.ac.jp/clipharm/result/05.html

    • Related Report
      2015 Annual Research Report
  • [Remarks] 九州大学大学院医学研究院臨床薬理学分野

    • URL

      http://www.med.kyushu-u.ac.jp/clipharm/

    • Related Report
      2014 Research-status Report

URL: 

Published: 2014-07-25   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi